Skip to content
healthcare.dev

SENNA-PLUS

NDC 68788-8780, Sennosides and Docusate Sodium, tablet, from Preferred Pharmaceuticals Inc..

Product NDC
68788-8780
Status
Listed
Labeler
Preferred Pharmaceuticals Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
OTC MONOGRAPH DRUG
Application
505G(a)(3)
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/68788-8780 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • SENNOSIDES8.6 mg/1
  • DOCUSATE SODIUM50 mg/1
Package NDCNDC-11Package
68788-8780-168788878001100 TABLET in 1 BOTTLE (68788-8780-1)
68788-8780-36878887800330 TABLET in 1 BOTTLE (68788-8780-3)
68788-8780-66878887800660 TABLET in 1 BOTTLE (68788-8780-6)
68788-8780-868788878008120 TABLET in 1 BOTTLE (68788-8780-8)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 68788-8780 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/68788-8780 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 68788-8780. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.